ERES East Resources Acquisition Company

eResearchTechnology Announces Extended Agreements With Two Key Customers Totaling $3.1 Million for EDC and Clinical Data Applications Technology and Services New Commitments Signed with Siemens and a Major Division of a Global Pharmaceutical Company PHILADELPHIA, Feb. 23 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT) , a leading e-research technology and services provider, announced today that agreements were accepted in the past 30 days totaling $3.1 million with Siemens Medical Solutions and the U.S.-based division of a major global pharmaceutical organization that extend the ability for these organizations to leverage eRT's EDC system and clinical data back office application suite across their respective enterprises. The agreements bring the total commitments to date from these organizations for eRT's clinical data technology and services solutions to more than $5 million. The latest agreements further extend the customers' access to eRT's entire application solutions offering,including its Enterprise Electronic Data Capture (EDC) platform, eResearch Community portal, and eResearch Network integrated back office suite, which features clinical data management, trial management and monitoring, and adverse event management and reporting solutions. "These exciting agreements represent key milestones in the roll-out of eRT's entire offering of clinical data technology solutions and services by segment leaders in the global pharmaceutical and healthcare industries," said Scott Grisanti, senior vice president of business development and chief marketing officer at eRT. "eRT's integrated enterprise EDC platform, clinical information portal, and end-to-end clinical data back office suite provide these organizations with a singlesource solution to manage all key aspects of the clinical trial process." Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technologyand services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development. Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand, and the company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the company's financial results can be found in the company's Reports on Forms 10-K and 10-Q filed with the Securities and Exchange Commission. DATASOURCE: eResearchTechnology, Inc. CONTACT: Joan Sterlacci of eResearchTechnology, +1-908-203-6473, or Matt Hayden of Hayden Communications, +1-760-487-1137, for eResearchTechnology Web site: http://www.ert.com/

Copyright